Type 2 Diabetes

Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.

Adults with type 2 diabetes who used an artificial intelligence-based app to manage their basal insulin reached their optimal dose in a shorter amount of time than adults receiving standard of care, according to a study data.

Glucagon-like peptide 1 receptor agonists were associated with a reduced risk for colorectal cancer among patients with type 2 diabetes, regardless of weight status, compared with other antidiabetics, according to research.

Walking at a faster speed may decrease the risk for developing type 2 diabetes, though more studies are needed to confirm the association, according to findings from a systematic review and meta-analysis.

Pregnant women with type 2 diabetes who used continuous glucose monitoring only had improvements in CGM metrics if they used the device more than 50% of the time, according to data published in Diabetes Technology & Therapeutics.

This blog launched in November 2016, and the inaugural post marked the occasion of the International Diabetes Federation’s World Diabetes Day, a global day of recognizing the burdens of diabetes on humans.

Greater salt consumption was linked to an increased risk for type 2 diabetes, according to a study published in Mayo Clinic Proceedings.

SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.